Frontiers in Cardiovascular Science Archived Talks
2017
The Future of Angiogenesis for the Treatment of Coronary Disease: A Historical Perspective
Frank W. Sellke, MD
Karl E. Karlson, MD and Gloria A. Karlson Professor of Cardiothoracic Surgery; Professor of Surgery Chief, Division of Cardiothoracic Surgery; Brown Medical School and Lifespan Hospitals
December 5, 2017
Mechanism and Therapy for Cerebral Cavernous Malformation
Mark L. Kahn, MD
Professor of Medicine, University of Pennsylvania
November 28, 2017
Heart Failure: Two Inflammatory Tales
Joseph A. Hill, MD, PhD
James T. Willerson, M.D., Distinguished Chair in Cardiovascular Diseases; Frank M. Ryburn Jr. Chair in Heart Research; Chief of Cardiology, UT Southwestern
November 21, 2017
Modeling Cardiovascular Development with Human Pluripotent Stem Cells
Gordon Keller, PhD
Director, McEwen Centre for Regenerative Medicine Senior Scientist, Ontario Cancer Institute
Toronto General and Western Hospital, Toronto, Canada
November 7, 2017
Gut Microbiota as Treatment Target for Cardio-Renal Risks
Wilson Tang, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University
October 31, 2017
Stanford + Takeda: Alliance for Innovative Medicines
Chaitan Khosla, PhD and Juan Harrison, Takeda
Khosla: Wells H. Rauser and Harold M. Petiprin Professor in the School of Engineering and Professor of Chemistry and, by courtesy, of Biochemistry
Harrison: Vice-President, Center for External Innovation, Takeda
October 24, 2017
Evidence-based Medicine: Precisely
John P. A. Ioannidis
C. F. Rehnborg Professor in Disease Prevention in the School of Medicine and Professor of Health Research and Policy (Epidemiology) and, by courtesy, of Statistics and of Biomedical Data Science
October 17, 2017
Signalosomes – Nodal Regulators and Therapeutic Targets for Heart Failure
Michael Kapiloff, MD, PhD
Associate Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
October 10, 2017
A Layperson’s Involvement in Fighting CVD and Stroke
Alvin L. Royse, JD
Immediate Past Chairman of American Heart Association, Councilman Town of Hillsborough, Retired Senior Partner Deloitt & Touche LLPx
September 12, 2017
The Natriuretic Peptides and Cardiometabolic Disease: From Base Pairs to Bedside
Thomas J. Wang, MD
Gottlieb C. Friesinger II Professor of Medicine; Director, Division of Cardiovascular Medicine; Physician-in-Chief, Vanderbilt Heart and Vascular Institute
May 16, 2017
Therapeutic Targeting of Cardiac (and Kidney) Fibrosis
Burns C. Blaxall, PhD, FAHA, FACC, FAPS
Director of Translational Science, Heart Institute Co-Director, Heart Institute Research Core & Biorepository Professor, UC Department of Pediatrics, University of Cincinnati
April 18, 2017
Renal Denervation in Heart Failure
David J. Lefer, PhD
Director, Cardiovascular Center of Excellence Professor of Pharmacology, LSU Health New Orleans
April 11, 2017
Beyond Biopsy: Using Genomics to Quantify Transplant Outcomes
Hannah Valantine, MD, MRCP
Hannah Valantine, MD, MRCP, Senior Investigator Laboratory of Tranplantation Genomics, NHLBI NIH Chief Officer for Scientific Workforce Diversity
March 21, 2017
Precision Medicine in PAH
Vinicio de Jesus Perez, MD
Assistant Professor of Medicine (Pulmonary and Critical Care Medicine)
March 7, 2017
The Flipside of Oxidative Stress: The World of Reductive Stress
Ivor Benjamin, MD
Ivor Benjamin, MD, Director, Cardiovascular Center Professor, Department of Medicine Division of Cardiology, Medical College of Wisconsin
February 21, 2017
Introduction to the Stanford Human Immune Monitoring Center
Holden Terry Maecker, PhD
Associate Professor (Research) of Microbiology and Immunology, Stanford
February 14, 2017
Rebuilding the Failing Heart with Cell Therapy: Roadblocks to Overcome
Jianyi "Jay" Zhang, MD, PhD
Chair, Department of Biomedical Engineering T. Michael and Gillian Goodrich Endowed Chair of Engineering Leadership Professor of Medicine, of Engineering School of Medicine, School of Engineering, The University of Alabama Birmingham
January 31, 2017
Pathophysiologic Implications of Peripheral Artery Disease: It’s About Life and Limb
Mark A. Creager, MD
Director, Heart and Vascular Center, Dartmouth-Hitchcock Medical Center Professor of Medicine, Geisel School of Medicine at Dartmouth
January 24, 2017
Role of MG53 in Metabolic Syndrome and Diabetic Cardiomyopathy
Rui-Ping Xiao, MD, PhD
Professor at the Institute of Molecular Medicine, Peking University, Beijing, China
January 17, 2017